Silvercrest Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-25,062
| Closed | -$17K | – | 901 |
|
|
2020
Q4 | $17K | Hold |
25,062
| – | – | ﹤0.01% | 808 |
|
|
2020
Q3 | $56K | Sell |
25,062
-1,575
| -6% | -$3.52K | ﹤0.01% | 744 |
|
|
2020
Q2 | $95K | Hold |
26,637
| – | – | ﹤0.01% | 717 |
|
|
2020
Q1 | $101K | Hold |
26,637
| – | – | ﹤0.01% | 673 |
|
|
2019
Q4 | $80K | Buy |
+26,637
| New | +$80K | ﹤0.01% | 740 |
|